Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Clotet, Bonaventura; Bellos, Nicholas; Molina, Jean-Michel; Cooper, David; Goffard, Jean-Christophe; Lazzarin, Adriano; Wöhrmann, Andrej; Katlama, Christine; Wilkin, Timothy; Haubrich, Richard; Cohen, Calvin; Farthing, Charles; Jayaweera, Dushyantha; Markowitz, Martin; Ruane, Peter; Spinosa-Guzman, Sabrina; Lefebvre, Eric; POWER 1 study group; POWER 2 study group

Clotet, Bonaventura; Bellos, Nicholas; Molina, Jean-Michel; Cooper, David; Goffard, Jean-Christophe; Lazzarin, Adriano; Wöhrmann, Andrej; Katlama, Christine; Wilkin, Timothy; Haubrich, Richard; Cohen, Calvin; Farthing, Charles; Jayaweera, Dushyantha; Markowitz, Martin; Ruane, Peter; Spinosa-Guzman, Sabrina; Lefebvre, Eric; POWER 1 study group; POWER 2 study group.

Afiliação